|
|
||||||||
J Thorac Cardiovasc Surg 1999;118:225-236
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL CARDIOVASCULAR DISEASE |
From the Clinic for Cardiovascular Surgerya and the Clinic for Pediatric Cardiology,b University Cantonal Hospital of Geneva, Geneva, Switzerland.
Address for reprints: Afksendiyos Kalangos, MD, PhD, Clinic for Cardiovascular Surgery, University Cantonal Hospital of Geneva, 24, Rue Micheli-du-Crest, 1211 Geneva 14, Switzerland.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
The diagnosis of AV disease was established by preoperative transthoracic 2-dimensional echocardiography with Doppler studies in the long- and short-axis, 5-chamber, and suprasternal notch sagittal views; MV disease was diagnosed by these studies in the long-axis and 4-chamber views. In all patients, the diameters of the aortic anulus and of the sinotubular junction were measured in the long-axis view by transthoracic echocardiography. Indications for operation included the presence of grade III or IV AI resulting in progressive increase in left ventricular dimensions. Three patients had peak systolic AV gradients higher than 20 mm Hg. In 21 patients the associated MV lesion was predominantly regurgitant (grade III), and in 3 patients it was predominantly stenotic with an MV area of less than 1 cm2. Seventeen patients (41%) had isolated AV repair. Twenty-four patients (59%) underwent AV repair in combination with MV repair. Patients with 4 valvular calcifications were excluded from valve repair procedures. None of the patients had active rheumatic carditis at the time of the operation.
Intraoperatively, in all patients, anatomic and functional study of the AV was done before and after cardiopulmonary bypass by transesophageal echocardiography.
Operative procedures.
Cardiopulmonary bypass with systemic hypothermia to 28°C was used in all patients. A left ventricular vent was placed through the right superior pulmonary vein. An aortotomy was made transversely, 2 cm above the right coronary artery, and extended downward toward the noncoronary sinus. In all cases, myocardial protection consisted of topical hypothermia and hyperkalemic crystalloid solution selectively infused into both coronary ostia, combined with retrograde cardioplegia in 7 patients. Repeated doses were given at intervals of 30 minutes throughout the operation.
First, the MV was explored through a left atriotomy. In 24 patients, concomitant MV repair consisted of 24 annuloplasties with a Carpentier-Edwards prosthetic ring (Baxter Healthcare Corp, Edwards Division, Santa Ana, Calif), 20 resections of secondary posterior and/or anterior chordae, 14 transpositions of anterior secondary chordae to the free edge of the anterior cusp, 6 chordal shortenings, and 3 commissurotomies with splitting of both papillary muscles.
At the aortic level, two stay sutures were first placed through the aortic wall close to the margin of the lower flap of the aortotomy at sites corresponding to the right-left coronary and the right-noncoronary commissures. Another stay suture was then placed at the midpoint of the upper flap of the aortotomy and fixed to the right superior border of the pericardium to adequately expose the AV. All aortic cusps were first inspected and measured with particular regard to the length of the free edge, the height of the cusps and commissures, and the appearance of the sinuses of Valsalva, the aortic anulus, and the sinotubular junction. In all patients, tricuspid morphology of the AV was confirmed. No patients had aortic cusp calcification. In 27 patients, a variable degree of cusp thickening and retraction was found with no evidence of cusp prolapse, 15 of whom needed cusp shaving. Six patients underwent concomitant aortic commissurotomy before proceeding to aortic cusp extension. Among the 14 remaining patients, 6 had one aortic cusp prolapse with elongation of the free edge and retraction in the height of the cuspal tissue: in 4 of them, the noncoronary cusp was prolapsed and in 2, the right coronary cusp was prolapsed. Eight patients had associated right and noncoronary cusp prolapse. In these cases, thickening of the prolapsing cusp was slight or moderate and concentrated especially on the free edge.
A large rectangular piece of anterior autologous pericardium was cut and applied on a wet woven Dacron patch with its mesothelial surface upward after the loose areolar tissue attached to its surface had been removed by blunt dissection. Subsequently, the shape of each pericardial patch was traced onto the Dacron patch, which served as a template for sizing, trimming, and handling of the attached pericardium according to the established dimensions (Fig l.A ). In Fig l
, B, the dimension B-D equals the diameter of the sinotubular junction plus 15% of this diameter to account for eventual loss resulting from pericardial shrinkage. The dimension G-I equals the length of the cusps free edge. The height of the pericardial extensions (A-F and E-J ) is equal to 3 mm. The dimension C-H is designed according to the height of each cusp in the middle of each ones axis. The height of the patches should be 5 mm or longer, depending on the height of the native cusps, so as to render equal the height of each extended aortic cusp at the sinotubular junction after repair. In our series, the mean height of pericardial extensions was 6 ± 0.4 mm, varying from 5 to 8 mm. The height of each patch was oversized by approximately 2 mm to allow for the suture line on the free edge of each corresponding aortic cusp. The cusps were first thinned if their mobility was restricted (Fig l
, C ). However, we tried to maintain a leathery consistency at cuspal free edges to better hold the sutures. A 5-0 double-ended polypropylene suture (Cardionyl, Péters Pharm Lab, Bobigny, France) was passed through the midpoint of the pericardial patch and through the midpoint of the corresponding cusp in such a manner that, when tied, the knot stayed on the aortic aspect. Two vertical 5-0 polypropylene "U" stitches were then passed through both commissural extensions of the pericardial patch (ABFG and DEIJ ) and aortic wall above both commissures (Fig l
, D ). These two commissural stitches were passed through pericardial pledgets and then tied outside the aorta. This was done to facilitate the next step of cusp extension, which consisted of running one of the arms of the tied suture over and over from the midpoint of the cusp, up the commissures, to the end point of pericardial extension on the aortic wall. A similar procedure was followed for the other half of the cusps free edge with the use of the second arm of the suture (Fig l
, D ). The suture was then brought out through the aortic wall and kept tense. The running sutures of the neighboring cusps brought out through the aortic wall at the same commissural extension level were then tied together over a pericardial pledget outside the aorta (Fig l
, E ). The Dacron patch, applied on the pericardium to aid in its handling, was then removed (Fig 1
, F ). The same procedure was repeated for each cusp with each specifically corresponding scalloped pericardial patch. Fig 1
, G, shows the final view of the reconstructed AV; the mesothelial surface of the pericardium is placed so as to correspond to the aortic aspects of the cusps. Fig 1
, H, shows the profile view of the reconstructed aortic cusps through a longitudinally opened aorta. Note that the height of each of the three pericardial extensions is different, owing to the variable amount of retraction of each of the native aortic cusps. With this technical approach, the extended aortic cusps remain separated from the aortic wall during systole because the total length of the free edge is smaller than the circumference of the bulging sinuses. This prevents eventual occlusion of the coronary ostia by direct apposition of the patches to the wall of the sinuses of Valsalva. We added two commissural extensions on each pericardial patch to ensure better balanced tension, especially concentrated on the commissural regions during systole when flexion of the free edges of the extended cusps is minimal. In this geometric configuration, the length of the free edge of each cusp, which is equivalent to 2 times the radius of the sinotubular junction plus 15%, is equal to the diameter of the aortic orifice and remains constant whether the valve is open or closed. Hence there is neither a lack of nor an excess of cusp tissue. The combined surface of the three cusps is approximately 15% larger than that of the sinotubular junction, assuring the coaptation of the cusps.
|
Statistical analysis.
Continuous data such as peak systolic AV gradient and left ventricular dimensions were expressed as mean ± standard deviation, and changes between measurement time points were analyzed by means of the paired Student t test. All tests were 2-tailed. Change across time in left ventricular dimensions and mean peak systolic AV gradients was estimated by means of a slope for each patient on and after discharge. AI grade was presented as frequency distributions. Kaplan-Meier methods were used to derive the probability for survival.
| Results |
|---|
|
|
|---|
Clinical follow-up.
Clinical follow-up was complete in all cases and ranged from 3 months to 5 years (median 3 years). No operative or early postoperative deaths have occurred and few perioperative complications. Two patients (5%) required mediastinal re-exploration for the control of postoperative hemorrhage, but none had wound complications or neurologic events. Postoperative atrial fibrillation, later converted into sinus rhythm, occurred in 8 patients who underwent concomitant MV repair. All the other patients remained in sinus rhythm after the operation. The mean postoperative hospital stay was 9 ± 2 days. One patient who had had concomitant AV and MV repair died 9 months after the operation of septicemia and multiple organ failure in another hospital with an apparently competent AV and MV. Actuarial survival was 97% at 1 year (95% confidence limits: 85%-99%) and has remained unchanged at 3 years (95% confidence limits: 81%-99%). Late follow-up revealed functional improvement in all patients. Ninety-three percent of the patients are now in New York Heart Association class I and 7% in class II according to the latest follow-up examinations. None of the children required reoperation for AI during the follow-up period. However, 2 patients who had had concomitant MV repair required reoperation because of failure of the MV repair during the second and fourth postoperative years, respectively. In both of them the MV was replaced by a mechanical prosthesis. Although none of them had AI, the AV was explored at the time of reoperation to have a precise idea regarding the outcome of the fresh autologous pericardium. Inspection showed slight homogeneous thickening of pericardial patches at their edges, but preserved pliability in their central portion. Cusp mobility was not altered, and pericardial commissural extensions were well incorporated into the aortic wall with complete neointimal covering. In the remaining patients who underwent concomitant MV repair, transthoracic echocardiographic examinations of the MV were stable during the entire follow-up period. No residual mitral insufficiency was detected after repair in 12 patients, and mild insufficiency was detected in 8 patients during the most recent follow-up examination. In all patients, anticoagulation with warfarin began on the second postoperative day and was stopped during the third postoperative month. No thromboembolic or hemorrhagic events were observed up to the most recent follow-up examinations.
Echocardiographic follow-up.
All patients had echocardiographic assessment during the third postoperative month, 40 during the sixth postoperative month, 31 during the first postoperative year, 29 during the second year, 23 during the third year, 13 during the fourth year, and 1 during the fifth postoperative year.
AI.
Transesophageal echocardiography on termination of cardiopulmonary bypass showed AI grade 0 in 29 patients and grade I in 12 patients. At discharge, the number of patients with grades 0 and I were 27 and 14 by transthoracic echocardiography, respectively. Exacerbation of AI from grade I to grade II was observed in 1 patient during the sixth postoperative month, but no further significant change in the degree of AI was found thereafter, throughout 16 postoperative months. This patient is now in New York Heart Association class I. Table I shows the frequency distributions of AI before the operation, during the operation after repair (by transesophageal echocardiography), at discharge, at 6 months after the operation, and during the follow-up period at yearly intervals. Diameters of the aortic anulus and the sinotubular junction were measured before the operation and during each transthoracic echocardiographic examination in all patients who were under 12 years of age at the time of the initial repair. Eight patients under the age of 12, operated on in 1993, had a mean aortic anulus diameter of 16.2 ± 1.2 mm (range 14-17.4 mm) just before the operation and a mean sinotubular junction diameter of 15.8 ± 0.9 mm (range 13.8-17 mm). Seven of them had grade 0 and 1 had grade I AI at discharge. Only 2 of them passed on to grade I AI during the fourth postoperative year, despite the growth of the aortic anulus to 19.7 mm and 19.4 mm, respectively, and that of the sinotubular junction to 18.8 mm and 18.3 mm, respectively. The late follow-up transthoracic echocardiogram of 1 of these children during the fourth postoperative year showed mobile cusps with pericardial extension maintaining pliability, resulting in a wide valve orifice opening in systole (Fig 2, A ) and good coaptation of extended cusps in diastolic closure (Fig 2, B ).
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Aortic cusp extension as an AV repair technique has already been reported by some authors as a valuable surgical tool in rheumatic AI, with satisfactory clinical midterm results regarding freedom from reoperation, thromboembolic events, and endocarditis.
3-7 Although the tendency over time has evolved from the use of heterologous
3-5,8 to autologous pericardium
6 and from a single-patch to a three-patch configuration,
9 in none of these series have the real dimensions of native aortic cusps been taken into account in the tailoring process of the patches used in cusp extension. The reason seems to be either total excision of the cusps or resection of the thickened part of the cusps, leaving an equal height of remaining tissue in each cusp before re-establishing the dimensions of a native AV. We believe that such techniques of AV replacement rather than cusp extension demand more patch tissue and may not have the same midterm or long-term outcome when compared with true cusp extension, where the amount of patch used is less and cuspal integrity of the native AV is preserved. We totally agree that the native AV should have a certain mobility despite fibrosis before proceeding to true cusp extension. In these series in which total or partial excision of cusps was performed, mean patients ages were older than those in our series.
3-7,9 Aging could favor more marked cuspal thickening and retraction in the context of evolving rheumatic valvular disease and, hence, no longer provide another surgical issue other than to totally or partially excise the cusps. On the other hand, we know that in the majority of cases of rheumatic AI, cusps have various degrees of pathologic involvement, rendering them nonidentical to each other in terms of height, length of the cuspal free edge, and thickness. Our series demonstrated that there was no similar value in terms of cuspal free edge and height between cusps of the same AV in 37 of 41 patients. This is the reason we have adopted a more geometric concept of cusp extension by adding the dimensions necessary to render cusps identical in height and length of cuspal free edge at the sinotubular junction, considered as the new coaptation level between extended cusps. Excessive stereotypic length of a patchs free edge without respect for the diameter of the sinotubular junction may unnecessarily create either festooned cuspal free edges or prolapse during diastole and floating patches during systole. On the other hand, equal heights of patches without taking into account the height of each aortic cusp can create unequal redundant cusps during diastole. Cuspal distortion and redundancy by excessive coaptation surface are major technical factors creating cuspal malalignment and thereby inducing turbulences. We believe that respecting the dimensions of native aortic cusps refines cuspal alignment, leading to better stress distribution, and may therefore prevent precarious shrinkage of the pericardial patches. Bahnson and associates
10 showed that a correctly sized and placed pericardial valve closely resembles an aortic homograft in the pulse duplicator. They concluded that a replaced cusp should be an accurate copy of the natural one.
The other important point in this technique is the choice of material. Although promising midterm clinical results have been reported by authors who have performed aortic cusp extension by glutaraldehyde-treated bovine pericardium after partially excising aortic cusps,
3,4 renewed interest is now focused on the use of autologous tissue and avoiding problems related to calcification and primary tissue failure found with heterograft bioprostheses and homograft valves, particularly in the pediatric population. However, Liao and colleagues
11 demonstrated in a rat model that autologous tissues treated with glutaraldehyde biologically behave like glutaraldehyde-treated xenogeneic ones: there was no difference between them regarding calcification tendency, so that neither was rendered preferable to the other. For this reason, short-time incubation (15 minutes) of the autologous pericardium in 0.62% glutaraldehyde-buffered solution was proposed for slowing down excessive scar formation and avoiding calcification.
12 This method showed encouraging results in both experimental and clinical studies, because such pericardium appeared to neither calcify nor shrink after implantation.
11,13,14 However, even short-time glutaraldehyde fixation may be enough to change the biologic identity of autologous pericardium, especially that of its protein-composed surface antigen by cross-linking protein chains. As a result, the short-time glutaraldehyde-treated autologous pericardium may be recognized as a "foreign body" by the host and induce certain inflammatory reactions.
11 Nevertheless, aortic cusp extension with short-time glutaraldehyde-treated autologous pericardium
9 seems to yield the same satisfactory clinical results as those obtained by mitral leaflet enlargement with similarly treated autologous pericardium.
14
On the other hand, the literature concerning the use of fresh autologous pericardium in valvular surgery seems to be divided between those who observed progressive contracture and loss of pliability of fresh pericardium
15-18 and those who observed preserved pliability despite some degenerative changes and healing.
19-22 Frater and associates,
16,17 who reported that mitral and tricuspid leaflet extension with fresh pericardium results in thickening, retraction, and hyaline deposition, recognized that technical difficulties and consequent malalignment of the patch might be a contributing factor. Ross and Olsen
18 also seemed to blame the technique more than the fresh pericardium itself. Besides the inherent difficulty of reconstructive AV surgery, most of the previous work of AV replacement or cusp extension with fresh autologous pericardium was done at a time when myocardial protection was practically nonexistent and techniques were not well established. Preservation of cusp mobility and coaptation, the lack of evidence of transvalvular turbulence and cuspal calcification, and the lack of progression in immediately detected mild transaortic gradients at midterm echocardiographic studies demonstrate that the process of pericardial and native valvular shrinkage seems to be delayed in our series. In addition, direct observation of the reconstructed AV in 2 patients requiring reoperation for failure of MV repair showed pliable and mildly thickened extended aortic cusps. This reinforces the hypothesis that the disparity between fresh and glutaraldehyde-treated autologous pericardium, although attributed to glutaraldehyde by some authors, could also be due to the refined aortic cusp extension technique, resulting in better tissue alignment and stress distribution.
Although it may seem conflicting, the other important observation in favor of fresh autologous pericardium is the homogeneous adaptation of the reconstructed AV in time, with the increase in diameters of the aortic anulus and sinotubular junction. Despite concern regarding the viability and growth capacity of fresh autologous pericardium, we believe that the expansible potential of untreated pericardium was preserved in 8 patients who were under 12 years of age at the time of initial repair. The preserved cusp motion and coaptation despite the increase in diameters of the aortic anulus and the sinotubular junction in repeated echocardiographic studies for up to 4 years indirectly proves that fresh pericardium does not limit its expansile potential with time. Holdefer, Edwards, and Dowling
23 reported in 1968 that untreated autologous pericardial valves in calves demonstrated good evidence of viability up to 51 days. Maintenance of viability was suggested by Thomas and coworkers
24 in dogs with untreated autologous pericardiumlined skeletal muscle ventricles in circulation for variable intervals up to 2 years. The pericardium was smooth, without evidence of thrombus formation or calcification. On the other hand, glutaraldehyde treatment for 10 minutes limited the expansile characteristics of pericardium used for replacing an excised aortic arch segment in piglets.
25 The untreated pericardial patch, when compared with the treated one, was significantly longer and wider, with no statistically significant difference in the strength of the patches 6 months after implantation. We believe that glutaraldehyde initially inhibits the change in size of the patch, contrary to the untreated pericardial patch in which it probably takes more time for fibrosis to definitively stop its expansion.
| Conclusion |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. A. Bacha, D. B. McElhinney, K. J. Guleserian, S. D. Colan, R. A. Jonas, P. J. del Nido, and G. R. Marx Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: Acute and intermediate effects on aortic valve function and left ventricular dimensions J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. McMullan, G. Oppido, B. Davies, Y. Kawahira, A. D. Cochrane, Y. d'Udekem d'Acoz, D. J. Penny, and C. P. Brizard Surgical strategy for the bicuspid aortic valve: Tricuspidization with cusp extension versus pulmonary autograft J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hawkins, P. C. Kouretas, R. Holubkov, R. V. Williams, L. Y. Tani, J. T. Su, L. M. Lambert, C. R. Mart, M. D. Puchalski, and L. L. Minich Intermediate-term results of repair for aortic, neoaortic, and truncal valve insufficiency in children J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1311 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, T. Karamlou, T. Bradley, W. G. Williams, G. S. Van Arsdell, J. G. Coles, J. Smallhorn, M. Nii, V. Guerra, and C. A. Caldarone Short and midterm results of aortic valve cusp extension in the treatment of children with congenital aortic valve disease. Ann. Thorac. Surg., October 1, 2006; 82(4): 1292 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rergkliang, V. Chittithavorn, A. Chetpaophan, and P. Vasinanukorn Surgery for Aortic Insufficiency Associated with Ventricular Septal Defect Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 61 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, A. N. Pelech, P. C. Frommelt, R. D.B. Jaquiss, G. M. Hoffman, K. A. Mussatto, and S. B. Litwin Complex aortic valve repair as a durable and effective alternative to valve replacement in children with aortic valve disease J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 551 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Hillman, L. Y. Tani, L. G. Veasy, L. L. Lambert, G. B. Di Russo, D. B. Doty, E. C. McGough, and J. A. Hawkins Current Status of Surgery for Rheumatic Carditis in Children Ann. Thorac. Surg., October 1, 2004; 78(4): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oshima, K. Koto, C. Shimazu, T. Misaki, F. Ichida, and I. Hashimoto Cusp Extension Technique for Bicuspid Aortic Valve in Turner-like Stigmata Asian Cardiovasc Thorac Ann, September 1, 2004; 12(3): 266 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hasaniya, S. R. Gundry, A. J. Razzouk, N. Mulla, and L. L. Bailey Outcome of aortic valve repair in children with congenital aortic valve insufficiency J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 970 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Grinda, C. Latremouille, A. J. Berrebi, R. Zegdi, S. Chauvaud, A. F. Carpentier, J.-N. Fabiani, and A. Deloche Aortic cusp extension valvuloplasty for rheumatic aortic valve disease: midterm results Ann. Thorac. Surg., August 1, 2002; 74(2): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Grinda, C. Latremouille, N. D'Attellis, A. Berrebi, S. Chauvaud, A. Carpentier, J.-N. Fabiani, and A. Deloche Triple valve repair for young rheumatic patients Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 447 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ahn, K.-H. Kim, and Y. J. Kim Midterm result of leaflet extension technique in aortic regurgitation Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 465 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov, E. H. Blackstone, J. White, M. Howard, R. Ahkrass, A. Marullo, and D. M. Cosgrove Durability of combined aortic and mitral valve repair Ann. Thorac. Surg., July 1, 2001; 72(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |